{"database": "openregs", "table": "dockets", "rows": [["FDA-2004-D-0040", "FDA", "Guidance for Industry on Listed Drugs, 30-Month Stays, and Approval of ANDAs and 505(b)(2) Applications Under Hatch-Waxman, as Amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003  Questions and Answers", "Nonrulemaking", "2021-09-01T01:01:44Z", "0b0000648046acf3"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2004-D-0040"], "units": {}, "query_ms": 9.372971020638943, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}